138 related articles for article (PubMed ID: 12504772)
41. Radiotherapeutic management of cervical carcinoma that complicates pregnancy.
Sood AK; Sorosky JI; Mayr N; Krogman S; Anderson B; Buller RE; Hussey DH
Cancer; 1997 Sep; 80(6):1073-8. PubMed ID: 9305707
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
43. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
[TBL] [Abstract][Full Text] [Related]
44. Altered fractionation in radiotherapy for head and neck cancer: too early to close the race and announce the winner?
Bentzen SM; Dische S
Radiother Oncol; 1999 May; 51(2):105-7. PubMed ID: 10435799
[No Abstract] [Full Text] [Related]
45. Retropharyngeal fibrosarcoma following radiation therapy for Hodgkin's lymphoma of the neck.
Spiegel J; Bogdasarian RS
Otolaryngol Head Neck Surg; 1985 Apr; 93(2):274-7. PubMed ID: 3921924
[No Abstract] [Full Text] [Related]
46. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
47. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy.
Haddad A; Peiffert D; Lapeyre M; Harter V; Buchheit I; Graff P
Brachytherapy; 2014; 13(6):597-602. PubMed ID: 24913434
[TBL] [Abstract][Full Text] [Related]
48. Calcium status following neck radiation therapy in Hodgkin's disease.
Nader S; Schultz PN; Fuller LM; Samaan NA
Arch Intern Med; 1984 Aug; 144(8):1577-8. PubMed ID: 6466016
[TBL] [Abstract][Full Text] [Related]
49. Radiotherapy during pregnancy: fact and fiction.
Kal HB; Struikmans H
Lancet Oncol; 2005 May; 6(5):328-33. PubMed ID: 15863381
[TBL] [Abstract][Full Text] [Related]
50. Radiation-induced hypothyroidism after treatment of head and neck cancer.
Feen Rønjom M
Dan Med J; 2016 Mar; 63(3):. PubMed ID: 26931197
[TBL] [Abstract][Full Text] [Related]
51. Radiotherapy for a solitary brain metastasis during pregnancy: a method for reducing fetal dose.
Magné N; Marcié S; Pignol JP; Casagrande F; Lagrange JL
Br J Radiol; 2001 Jul; 74(883):638-41. PubMed ID: 11509400
[TBL] [Abstract][Full Text] [Related]
52. Palliative radiation therapy for head and neck cancer: toward an optimal fractionation scheme.
Chen AM; Vaughan A; Narayan S; Vijayakumar S
Head Neck; 2008 Dec; 30(12):1586-91. PubMed ID: 18798313
[TBL] [Abstract][Full Text] [Related]
53. Radiotherapy for supradiaphragmatic Hodgkin's disease: determination of the proper fetal shielding conditions using Monte Carlo methodology.
Mazonakis M; Tzedakis A; Varveris C; Damilakis J
Phys Med; 2011 Oct; 27(4):181-7. PubMed ID: 21216645
[TBL] [Abstract][Full Text] [Related]
54. Radiation therapy in pregnancy: risk calculation and risk minimization.
Greskovich JF; Macklis RM
Semin Oncol; 2000 Dec; 27(6):633-45. PubMed ID: 11130470
[TBL] [Abstract][Full Text] [Related]
55. Cesarean section in a pregnant patient with an anterior mediastinal mass and failed supradiaphragmatic irradiation.
Martin WJ
J Clin Anesth; 1995 Jun; 7(4):312-5. PubMed ID: 7546758
[TBL] [Abstract][Full Text] [Related]
56. [Hodgkin's disease and pregnancy. 3 case reports and a review of the literature].
Abboud J; Nasrallah T; Chahine G; Nasnas R
J Gynecol Obstet Biol Reprod (Paris); 1993; 22(7):783-6. PubMed ID: 7508468
[TBL] [Abstract][Full Text] [Related]
57. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
58. Anaplastic cardcinoma of the thyroid in a population irradiated for Hodgkin Disease, 1910--1960.
Gétaz EP; Shimaoka K
J Surg Oncol; 1979; 12(2):181-9. PubMed ID: 385997
[TBL] [Abstract][Full Text] [Related]
59. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003.
Fu KK; Pajak TF; Trotti A; Jones CU; Spencer SA; Phillips TL; Garden AS; Ridge JA; Cooper JS; Ang KK
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):7-16. PubMed ID: 10924966
[TBL] [Abstract][Full Text] [Related]
60. Late effects of radiotherapy for Hodgkin's disease in adolescence.
Shehata WM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1276. PubMed ID: 15752911
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
